RLYB
Rallybio Corp
16.90$
-1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.2% | -14.1% | -7.0% | -14.5% | -13.8% | -14.9% | -12.0% | +32.7% | -8.0% | -12.5% | +80.0% | |
| – | -13.3% | -14.2% | -7.2% | -14.4% | -13.3% | -15.4% | -12.4% | +32.6% | -8.1% | -12.7% | +81.8% | |
| – | +27.9% | -21.2% | -13.6% | +51.9% | -45.1% | +6.3% | -36.1% | +240.1% | -2.3% | +31.6% | +124.8% | |
| – | -9.4% | -14.3% | -5.9% | -15.2% | -12.8% | -16.8% | -16.0% | +29.7% | -7.7% | -14.5% | +98.4% | |
| – | -1.8% | +8.1% | +21.7% | -34.0% | -21.2% | -39.4% | +28.9% | -8.2% | -7.0% | -2.6% | -15.0% | |
| – | -1.5% | +8.9% | +20.6% | -32.7% | -23.8% | -37.4% | +28.9% | -10.3% | -6.6% | -2.0% | -13.8% | |
| – | +0.9% | +1.8% | +1.3% | +1.8% | -33.0% | -24.7% | -50.0% | +55.2% | +4.4% | +5.3% | – | |
| – | +110.3% | -51.8% | +159.1% | -52.1% | -52.3% | +43.9% | -70.3% | +126.1% | -53.2% | +646.0% | -11.4% | |
| – | -14.1% | -16.0% | -10.3% | -11.5% | -12.9% | -12.3% | -15.0% | +37.1% | -8.1% | -13.2% | +88.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +0.3% | +8.2% | +1.1% | +0.2% | +0.3% | +0.1% | +0.5% | -6.2% | +7.7% | +1.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.